The AITX study is an international, multicenter survey exploring how kidney transplant recipients perceive artificial intelligence (AI) in medicine and, specifically, a system that predicts graft loss risk. Through an open-ended online questionnaire distributed across transplant centers and patient associations in France and the United States, the study captures patients' expectations, concerns, and the perceived impact of AI-driven prediction on their daily lives. Responses are analyzed using large language models (LLMs) with systematic human verification. The study aims to ensure that the deployment of AI in transplantation is ethical, transparent, and patient-centered.
* Age ≥ 18 years
Fluency in French or English
Electronic consent given
Severe cognitive impairment preventing comprehension
Technical inability to access the questionnaire
The study targets adult kidney transplant recipients (≥18 years), fluent in French or English, and able to provide electronic consent. Patients with severe cognitive impairment preventing comprehension or technical inability to access the online questionnaire are excluded. Participants are recruited through transplant centers and patient associations in France and the United States. The questionnaire will be distributed to an estimated 10,000-20,000 patients, with an expected response rate of 10-15%
Cohort
Prospective
Not listed
11
Trial groupsSee each trial group below.
Perceptions of patients about AI
Perceptions of kidney transplant recipients regarding the use of artificial intelligence, assessed with a questionnaire
Perceptions of patients about the use of a graft failure prediction system
This study aims to explore the perceptions of kidney transplant recipients regarding the use of a graft loss risk prediction system, assessed with a questionnaire
Click on the lead sponsor to view all of their trials.
